News
-
Federal Council proposes assumption of costs for medical products from abroad
-
Coronavirus: ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
-
Coronavirus: majority positive response to the extension of the certificate obligation
-
Federal Supreme Court, Decision 9C_710/2020 of 10 August 2021
-
Implementing ordinance for facilitated access to treatment with medicinal cannabis in the consultation phase
-
Federal Administrative Court, Decision C-4697/2019 of 9 August 2021
-
Federal Supreme Court, Decision 2C_149/2021 of 3 August 2021
-
Artificial intelligence in medicine regulation
-
Electronic patient dossier: Federal Council wants to promote dissemination and use in a targeted manner
-
New Work Sharing Initiative from the Access Consortium for assessment of Biosimilar applications
-
Benchmarking 2021 - Comparison of Swiss approval times for human medicines with the EU and the USA
-
Interoperability of track and trace systems: key to public health protection
-
Federal Administrative Court, Decision C-5008/2019 of 14 July 2021
-
Federal Supreme Court, Decision 9C_30/2020 of 14 June 2021
-
EU recognises Swiss COVID certificate
-
Federal Supreme Court, Decision 9C_563/2020 of 7 June 2021
-
Court of Justice of the European Union, Case C-178/20 of 8 July 2021 (Pharma Expressz)
-
KPTPO: Updating of annexes 5, 6 and 8 – 10
-
Federal Administrative Court, Decision C-4967/2019 of 8 June 2021
-
Federal Supreme Court, Decision 2C_119/2021 of 1 June 2021
-
Simplified access to medicines for acute pain and migraine at the pharmacy